Home / Insights / What Is Sponsor Oversight in Clinical Trials?
Sponsor Oversight
What Is Sponsor Oversight in Clinical Trials?
Sponsor oversight is the work of knowing whether a clinical trial is being run as the sponsor intended. It is not a second copy of the CRO's monitoring plan, and it is not a monthly slide that repeats the CRO's own status.
ICH E6 is clear that a sponsor may transfer trial-related duties to a CRO, but the sponsor remains responsible for the trial data's quality and integrity. Outsourcing the activity does not outsource accountability. That is the practical problem sponsor oversight is meant to solve.
What oversight actually looks at
Useful oversight looks through the activity to the evidence. Are monitoring visits happening when the plan says they should? Are reports submitted in time to be useful? Are protocol deviations being classified consistently? Are the same sites generating the same queries, month after month, with no owner?
A sponsor who can answer those questions can intervene while options still exist. A sponsor who sees only a green dashboard finds the problem when enrolment, data, or an inspection has already moved on.
Oversight is not the same as doing the monitoring
Clinical monitoring is the visit, the source review, the report, and the follow-up at site. Oversight is the independent reading of that work: report review, metrics, trend, escalation, and, where needed, an oversight visit. Both matter. Confusing them is how sponsors either micromanage the CRO or disappear from their own study.
For a closer comparison, see clinical monitoring versus sponsor oversight.